GRIFFITHS, C.; PAPP, K.; SONG, M.; MILLER, M.; YOU, Y.; SHEN, Y.-K.; HAN, C.; BLAUVELT, A. Maintenance of Response With up to 4 Years of Continuous Guselkumab Treatment: Results From the VOYAGE 1 Phase 3 Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S17, 2019. DOI: 10.25251/skin.3.supp.17. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/744. Acesso em: 22 jul. 2024.